Related references
Note: Only part of the references are listed.Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder
Ann Childress et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
David Coghill et al.
BMC PSYCHIATRY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Amphetamine, past and present - a pharmacological and clinical perspective
David J. Heal et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges
Frank A. Lopez et al.
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2013)
Advances in understanding and treating ADHD
Kevin M. Antshel et al.
BMC MEDICINE (2011)
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Mark Wolraich et al.
PEDIATRICS (2011)
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
Sandra J. J. Kooij et al.
BMC PSYCHIATRY (2010)
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
Jan Buitelaar et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2010)
An Update on Central Nervous System Stimulant Formulations in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Benjamin Chavez et al.
ANNALS OF PHARMACOTHERAPY (2009)
Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder
M. Feldman et al.
PAEDIATRICS & CHILD HEALTH (2009)
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study
TJ Spencer et al.
CLINICAL THERAPEUTICS (2006)
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall
JJ McGough et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2003)
Share Paper
